1. |
Tajan M, Paccoud R, Branka S, et al. The RASopathy family: consequences of germline activation of the RAS/MAPK pathway. Endocr Rev, 2018, 39(5): 676-700.
|
2. |
郁婷婷, 张欢欢, 李牛, 等. Cardio-facio-cutaneous 综合征 2 例报告并文献复习. 临床儿科杂志, 2017, 35(4): 286-289.
|
3. |
肖海, 张照婧, 吕雪, 等. 二代测序技术在 Cardio-facio-cutaneous 综合征诊断中的应用研究. 重庆医学, 2018, 47(8): 1074-1076.
|
4. |
陈佩瑜, 耿岚岚. 心-面-皮肤综合征 1 例. 实用医学杂志, 2017, 33(21): 3680.
|
5. |
Reynolds JF, Neri G, Herrmann JP, et al. New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement —the CFCS syndrome. Am J Med Genet, 1986, 25(3): 413-427.
|
6. |
Rauen K A. The RASopathies. Annu Rev Genomics Hum Genet, 2013, 14: 355-369.
|
7. |
Myers A, Bernstein JA, Brennan ML, et al. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome. Am J Med Genet A, 2014, 164A(11): 2814-2821.
|
8. |
刘晓亮, 傅立军. Noonan 综合征的诊治进展. 临床儿科杂志, 2016, 34(01): 64-67.
|
9. |
Pierpont ME, Magoulas PL, Adi S, et al. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics, 2014, 134(4): e1149-e1162.
|
10. |
Kavamura MI, Peres CA, Alchorne MM, et al. CFCS index for the diagnosis of cardiofaciocutaneous syndrome. Am J Med Genet, 2002, 112(1): 12-16.
|
11. |
Allanson JE. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: a comparison of three disorders of the Ras/MAPK signaling pathway. American Journal of Medical Genetics (Part A), 2016, 170(10): 2570-2577.
|
12. |
Zenker M, Lehmann K, Schulz AL, et al. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet, 2007, 44(2): 131-135.
|
13. |
Yoon G, Rosenberg J, Blaser S, et al. Neurological complications of cardio-facio-cutaneous syndrome. Dev Med Child Neurol, 2007, 49(12): 894-899.
|
14. |
Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet, 2006, 38(3): 331-336.
|
15. |
Schubbert S, Bollag G, Lyubynska N, et al. Biochemical and functional characterization of germ line KRAS mutations. Mol Cell Biol, 2007, 27(22): 7765-7770.
|
16. |
Gremer L, Merbitz-Zahradnik T, Dvorsky R, et al. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Hum Mutat, 2011, 32(1): 33-43.
|